CAS 1188275-92-4

Narnatumab

CAS : 1188275-92-4

Narnatumab (IMC-RON8) is a humanized antibody that targets the macrophage-stimulating receptor 1 (RON). Narnatumab blocks the binding of RON to its ligand, macrophage-stimulating protein (MSP), and inhibits receptor activation, thereby suppressing tumor cell proliferation and migration. It is being investigated for the treatment of advanced malignant solid tumors.

Degré de pureté : >95%

Couleur et forme : Liquid

Masse moléculaire : 145.8 kDa (Predicted)

Ref: TM-T77409

Narnatumab

CAS : 1188275-92-4

Degré de pureté : 95%

Masse moléculaire : G/Mol

Ref: IN-DA0294VP